The effects of vasoactive agents, platelet agonists and anticoagulation on thrombelastography

Acta Anaesthesiologica Scandinavica

Volumn 51, Issue 9, 2007, Pages 1237-1244

  Kawasaki, J ^a   Katori, N ^b   Taketomi, T ^c   Terui, K ^a   Tanaka, K A ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulation; Milrinone; Olprinone; Platelet activation; Thrombelastography

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTICOAGULANT AGENT; ARGATROBAN; COLLAGEN; DESMOPRESSIN ACETATE; HEPARIN; LOPRINONE; MILRILA; MILRINONE; NORADRENALIN; UNCLASSIFIED DRUG; VASOACTIVE AGENT; VASOPRESSIN;

ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY;

ADENOSINE DIPHOSPHATE; ANTICOAGULANTS; BLOOD PLATELETS; CARDIOTONIC AGENTS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOSPHODIESTERASE INHIBITORS; PLATELET AGGREGATION; STATISTICS, NONPARAMETRIC; THROMBELASTOGRAPHY; VASOCONSTRICTOR AGENTS;

EID: 34548590837     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01434.x     Document Type: Article

References (35)

1. Tanaka KA. The assessment of platelet function. TATM 2006 8 : 95 105.
2. Kawasaki J, Tanaka KA, Sato N, Saitoh T, Shimizu M. Blood component therapy guided by celite-activated thromboelastography for perioperative coagulopathy. J Anesth 2002 16 : 79 83.
3. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999 88 : 312 9.
4. Shattil SJ, Budzynski A, Scrutton MC. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood 1989 73 : 150 8.
5. Kikura M, Kazama T, Ikeda T, Sato S. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Platelets 2000 11 : 446 58.
6. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005 49 : 222 31.
7. Nielsen VG. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of Factor XI. Acta Anaesthesiol Scand 2006 50 : 168 72.
8. Coughlin SR. Protease-activated receptors and platelet function. Thromb Haemost 1999 82 : 353 6.
9. Tanaka KA, Szlam F, Kelly AB, Vega JD, Levy JH. Clopidogrel (Plavix) and cardiac surgical patients. Implications for platelet function monitoring and postoperative bleeding. Platelets 2004 15 : 325 32.
10. Xiao Z, Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 1998 97 : 251 6.
11. Matsuo T, Nakao K, Yamada T, Matsuo O. Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit. Thromb Res 1986 41 : 33 41.
12. Walsh PN. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Thromb Haemost 2001 86 : 75 82.
13. Despotis GJ, Ikonomakou S, Levine V, Joiner-Maier D, Santoro SA, Joist JH. Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood. Thromb Res 1997 86 : 205 19.
14. Ereth MH, Nuttall GA, Santrach PJ, Klindworth JT, Oliver WC Jr., Schaff HV. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass. Anesthesiology 1998 88 : 962 9.
15. Shore-Lesserson L, Ammar T, DePerio M, Vela-Cantos F, Fisher C, Sarier K. Platelet-activated clotting time does not measure platelet reactivity during cardiac surgery. Anesthesiology 1999 91 : 362 8.
16. Kawasaki J, Katori N, Kodaka M, Miyao H, Tanaka KA. Electron microscopic evaluations of clot morphology during thrombelastography. Anesth Analg 2004 99 : 1440 4 table of contents.
17. Gawaz M, Ruf A, Pogatsa-Murray G et al. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab. Importance of internal pool of glycoprotein IIb-IIIa receptors. Thromb Haemost 2000 83 : 915 22.
18. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. J Clin Invest 1996 98 : 863 74.
19. Wielders SJH, Beguin S, Hemker HC, Lindhout T. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Arteriosclerosis Thromb Vasc Biol 2004 24 : 1138 42.
20. Jang IK, Lewis BE, Matthai WH Jr., Kleiman NS. Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study. J Thromb Thrombolysis 2004 18 : 31 7.
21. Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005 3 : 85 92.
22. Sha K, Iwata M, Mori M et al. Evaluation of the different doses of olprinone for continuous infusion after cardiopulmonary bypass for coronary artery bypass surgery. Masui 2003 52 : 621 5.
23. Ikeda Y. Antiplatelet therapy using cilostazol, a specific PDE3 inhibitor. Thromb Haemost 1999 82 : 435 8.
24. Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 2005 46 : 1705 9.
25. Katori N, Szlam F, Levy JH, Tanaka KA. A novel method to assess platelet inhibition by eptifibatide with thromboelastograph. Anesth Anlag 2004 99 : 1794 9.
26. Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC. Comparison of modified thrombelastograph and plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 2005 145 : 309 15.
27. Kawai H, Yamamoto T, Hara H, Tamao Y. Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban. Thromb Res 1994 74 : 185 91.
28. Elg M, Gustafsson D, Deinum J. The importance of enzyme inhibition kinetics for the effect of thrombin inhibitors in a rat model of arterial thrombosis. Thromb Haemost 1997 78 : 1286 92.
29. Cantwell AM, Di Cera E. Rational design of a potent anticoagulant thrombin. J Biol Chem 2000 275 : 39827 30.
30. Li W, Johnson DJD, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 2004 11 : 857 62.
31. Heinemann A, Wachter CH, Fickert P, Trauner M, Stauber RE. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats. Hepatology 1998 28 : 646 54.
32. Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 1992 77 : 38 46.
33. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005 49 : 373 8.
34. Nielsen VG. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions. Acta Anaesthesiol Scand 2005 49 : 1263 71.
35. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005 49 : 1163 71.